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Abstract
EmergingB. cereus strains that cause anthrax-like disease have been isolated in Cameroon
(CA strain) and Côte d’Ivoire (CI strain). These strains are unusual, because their genomic
characterisation shows that they belong to the B. cereus species, although they harbour two
plasmids, pBCXO1 and pBCXO2, that are highly similar to the pXO1 and pXO2 plasmids of
B. anthracis that encode the toxins and the polyglutamate capsule respectively. The virulence
factors implicated in the pathogenicity of theseB. cereus bv anthracis strains remain to be
characterised. We tested their virulence by cutaneous and intranasal delivery in mice and
guinea pigs; they were as virulent as wild-type B. anthracis. Unlike as described for pXO2-
cured B. anthracis, the CA strain cured of the pBCXO2 plasmid was still highly virulent, show-
ing the existence of other virulence factors. Indeed, these strains concomitantly expressed a
hyaluronic acid (HA) capsule and the B. anthracis polyglutamate (PDGA) capsule. The HA
capsule was encoded by the hasACB operon on pBCXO1, and its expression was regulated
by the global transcription regulator AtxA, which controls anthrax toxins and PDGA capsule in
B. anthracis. Thus, the HA and PDGA capsules and toxins were co-regulated by AtxA.We ex-
plored the respective effect of the virulence factors on colonisation and dissemination of CA
within its host by constructing bioluminescent mutants. Expression of the HA capsule by itself
led to local multiplication and, during intranasal infection, to local dissemination to the adja-
cent brain tissue. Co-expression of either toxins or PDGA capsule with HA capsule enabled
systemic dissemination, thus providing a clear evolutionary advantage. Protection against in-
fection byB. cereus bv anthracis required the same vaccination formulation as that used
against B. anthracis. Thus, these strains, at the frontier between B. anthracis and B. cereus,
provide insight into how the monomorphic B. anthracismay have emerged.
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Author Summary
Anthrax is caused by the bacterium Bacillus anthracis that affects all mammals worldwide.
It emerged more than 10,000 years ago from a Bacillus cereus precursor. In the past decade,
B. cereus bacteria were isolated in the USA from anthrax-like pneumonia cases. They har-
bour one virulence plasmid very similar to the toxin–encoding plasmid of B. anthracis. Re-
cently, an anthrax-like disease in great apes in Africa was caused by emerging B. cereus
strains, named B. cereus biovar anthracis. These strains are atypical as they possess both
plasmids coding for toxin and capsule similar to those so far found only in B. anthracis.
These unusual pathogenic B. cereus are currently neglected. We explored the virulence of
these pathogens and their colonisation and dissemination capacity within the murine host.
We found that these toxinogenic strains harbour two capsules, the classical B. anthracis
capsule and an additional polysaccharidic capsule. This latter capsule confers virulence
alone or in combination with toxins. Both capsules are concomitantly expressed, under
the control of a common global regulator and host signals. Our results show that acquisi-
tion of new genetic information by these B. cereus clearly gives them a selective advantage,
favouring their dissemination within infected hosts and the environment.
Introduction
Bacillus cereus and Bacillus anthracis are genetically closely related and belong to the B. cereus
group [1,2]. B. cereus strains display a dynamic genome and carry numerous mobile genetic el-
ements, including several plasmids [2]. Genetic exchange is frequent between bacteria of the B.
cereus lineage [2,3,4,5]. Most B. cereus isolates are non pathogenic. Some strains however may
cause food poisoning, due to production of toxins, emetic toxin or enterotoxins; B. cereus can
also cause opportunistic and nosocomial infections especially in immunocompromised indi-
viduals [2]. B. anthracis, the etiological agent of anthrax, is highly monomorphic and possesses
specific pathogenic properties that differentiate it from B. cereus [2]. The B. anthracis lineage is
genetically defined by particular chromosomal-borne characteristics. These include four chro-
mosomal lambdoid prophages and a particular nonsense mutation in the plcR gene resulting in
the absence of a functional PlcR protein, which is a global regulator in the B. cereus group [2,6].
Anthrax is an acute lethal disease associating infection and toxemia [7]. The virulence proper-
ties of B. anthracis that are characteristic of anthrax are due to the presence of two particular
plasmids, pXO1 and pXO2, which are responsible for toxin production and capsule synthesis, re-
spectively. The pagA, lef and cya genes, located within a 44.8 kb pathogenicity island (PAI) [8]
on pXO1, code for the tripartite toxin components: the protective antigen PA, the lethal factor
LF, and the edema factor EF. These proteins act in combination to form the lethal toxin (LT) and
the edema toxin (ET) [9]. The pXO2 plasmid carries the cap BCADE operon, encoding the en-
zymes involved in the synthesis and anchoring of the poly-γ-D-glutamate capsule (PDGA). This
capsule inhibits phagocytosis, functions as a non-immunogenic surface, enables bacterial adhe-
sion to the endothelium and is essential for virulence [9,10,11]. AtxA is a global regulator of viru-
lence that is encoded by atxA located within the PAI on pXO1. AtxA activates the transcription
of toxin and capsule genes, at 37°C in the presence of CO2 and bicarbonate [12].
It is generally considered that B. anthracis strains differ from other strains in the B. cereus
group by the presence of pXO1 and pXO2. However, the emergence of B. cereus strains that
possess pathogenic properties similar to those of B. anthracis has blurred the frontiers between
the two species [13,14]. At least four B. cereus isolates (G9241, 03BB87, 03BB102 and Elc2)
have been associated with severe to fatal pneumonia resembling cases of inhalational anthrax
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[13,14,15,16]. They were isolated from metal workers living in different parts of Texas and
Louisiana, over a period of more than a decade. These strains harbour a pXO1-like plasmid,
named pBCXO1, that shows 99.6% similarity to pXO1 and therefore expresses the anthrax
toxin genes. They harbour a functional PlcR [13,16] and express various genes belonging to
the PlcR regulon, in particular those encoding haemolysins, proteases and phospholipases
[2,6,17]. Although they are encapsulated, their capsule is not made of poly-γ-D-glutamate [15],
but is instead of a polysaccharide nature [13]. The G9241 strain carries a second large plasmid,
pBC218, which carries the bpsX-H operon encoding a polysaccharide capsule [13,18]. This
plasmid, or one very similar to it, has been found in the 03BB87 strain [13]. Furthermore, an
operon, hasACB, located on pBCXO1 and encoding a hyaluronic acid capsule, is functional in
the G9241 strain, in contrast to B. anthracis in which the hasA gene is mutated [18,19]. The
G9241 strain is therefore able to synthesize two polysaccharide capsules [18].
Emerging B. cereus strains have been isolated from great apes that died from an anthrax-like
disease in Cameroon (CA) and Côte d’Ivoire (CI) [20,21,22,23]. These unusual strains are unlike
any other isolated before and were originally designated as “Bacillus cereus variety anthracis”, but
were later renamed B. cereus biovar (bv) anthracis to comply with database requirements. Their
genomic characterization showed that they belong to the B. cereus species although they harbour
two plasmids, pBCXO1 and pBCXO2 (initially designated as pCI-XO1 and pCI-XO2, respective-
ly), that are highly similar to the pXO1 and pXO2 B. anthracis plasmids [20,23,24]. These strains
produce active edema and lethal toxins and they are encapsulated with a PDGA capsule [20,24].
These features clearly indicate that plasmids no longer unambiguously differentiate B. anthracis
from other members of the B. cereus group. The CA and CI strains do not carry the plcRmuta-
tion specific to B. anthracis. However, these strains do contain a frameshift mutation at the 3’
end of the gene that creates a four amino-acid extension at the C-terminus of the protein [24].
The mutant protein is probably inactive, as these strains do not express the degradative enzymes
controlled by PlcR and are non-haemolytic. Therefore, the CA and CI strains possess phenotypic
properties characteristic of B. anthracis which makes these strains difficult to classify [23,24].
Most recently, anthrax was considered among the three major neglected zoonotic diseases
that need recognition [25]. This is even truer to the atypical pathogenic B. cereus CA and CI
strains whose virulence and interactions with the host remain to be elucidated. In this study,
we characterise the virulence factors implicated in the pathogenicity of the CA and CI strains
and describe their effect on colonisation and dissemination within the host. We show that the
CA and CI strains harbour two concomitantly expressed capsules, a PDGA capsule similar to
that of B. anthracis, and a hyaluronic acid (HA) capsule. The genes involved in the production
of both capsules are regulated by the global regulator AtxA. We explored the role of each cap-
sule and toxin, as well as their concerted action in vivo.
Materials and Methods
Ethics statement
All the animal experiments described in the present study were conducted at the Institut Pas-
teur according to the European Union guidelines for the handling of laboratory animals
(http://ec.europa.eu/environment/chemicals/lab_animals/home_en.html) and were approved
by the Institut Pasteur animal care and use committee (CETEA n°2013–0088). All efforts were
made to minimize suffering.
Bacterial strains and growth conditions
B. cereus bv anthracis and Bacillus anthracis strains used in this study are listed in Table 1. Bacteria
were grown in Brain Heart Infusion (BHI) broth or on BHI agar (Difco, http://www.bd.com/ds)
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unless otherwise noted. Antibiotics were used when necessary at the following concentrations:
spectinomycin at 100 μg/ml and erythromycin at 5 μg/ml. B. cereus bv anthracis and B. anthracis
spores were produced as described previously [26].
Construction of B. cereus bv anthracis CAmutant strains
The presence of the plasmids pBCXO1 and pBCXO2 was verified by multiplex PCR analysis
[27]. The CA strain was cured of the pBCXO2 plasmid as described for B. anthracis [28], result-
ing in the CAR strain. Loss of pBCXO2 was confirmed by multiplex PCR. Mutant strains were
constructed by heterogramic conjugation and the conjugative E.coli strain HB101 (pRK212.1)
was used to transfer the relevant plasmids [29], as described previously for the construction of B
anthracismutant strains [30,31,32]. CAP and CAR-P mutants in which the pagA gene is inactive
were constructed as described for the 9602P B anthracis strain [33]. The bioluminescent deriva-
tives CAR-Plux, CARlux and CAPlux were constructed through conjugation with involving the
pIG6–19 plasmid carrying the luxABCDE operon of Photorhabdus luminescens under the control
of the pagA promoter, as described for the construction of the B. anthracis bioluminescent strains
[30]. The replicative pDAC-atxA plasmid [34], which contains atxA under the control of the
Pspac promoter [35] was used for AtxA complementation experiments.
For the construction of CA-H(ΔhasA) and CAR-H(ΔhasA) mutant strains, the hasA gene
sequences from position 106 to 712 and from position 2012 to 2527 were amplified from CAR
genomic DNA with the following primers: GGTACCCTAATAATTATCTATGGAAGTGGA
GGAGGG / CCCGGGCGATCTAAATT TCTCATAGGACGTATAAGG for fragment 106–712
(KpnI and XmaI sites underlined) and CCCGGGGCTTTACTAACTATTAAATCTAATGGTT
GG / CTGCAGCAATTGCTTGAGACATGGATACGTAGAGCT for fragment 2012–2527
(XmaI and PstI sites underlined). The resulting PCR products were inserted into the pGEM-T
easy plasmid which was introduced into TG1 E. coli. These hasA gene sequences were digested
Table 1. B. cereus bv anthracis and B. anthracis strains used in this study.
Strains Genotype or description Source or reference
CI pBCXO1+; pBCXO2+; pCI-14 Klee et al., 2006
CA pBCXO1+; pBCXO2+ Klee et al., 2006
CAP pBCXO1+, ΔpagA; pBCXO2+; Spcr This study
CA-H pBCXO1+, ΔhasA; pBCXO2+; Spcr This study
CAR pBCXO1+ This study
CAR-P pBCXO1+, ΔpagA; Spcr This study
CAR-R pBCXO1 & pBCXO2 cured This study
CAR-H pBCXO1+, ΔhasA; Spcr This study
CAR-20 pBCXO1+, atxA* This study
CAR-20atxA pBCXO1+, pDACatxA::Pspac-atxA; Spcr This study
CAPlux pBCXO1+, ΔpagA, PpagA-lux; pBCXO2+; Spcr, Ermr This study
CARlux pBCXO1+, PpagA-lux; Ermr This study
CAR-Plux pBCXO1+, ΔpagA, PpagA-lux; Spcr, Ermr This study
Ba7702 Sterne strain, 34F2; pXO1+ Laboratory stock
Ba9602 pXO1+; pXO2+ Berthier et al., 1996
BaVollum pXO1+; pXO2+ ATCC 14578**
atxA*: Inactive atxA through spontaneous mutations; Ba: B. anthracis
**Kindly provided by Wolfgang Beyer, Hohenheim University, Stuttgart, Germany.
doi:10.1371/journal.pntd.0003455.t001
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with KpnI/XmaI or XmaI/PstI and were inserted sequentially into the conjugative suicide plas-
mid pAT113 cut by the same enzymes [36], resulting in the pCB12 plasmid. The pUC1318 spec-
tinomycin resistance cassette was extracted through SmaI/HincII digestion and was inserted into
the SmaI-digested pCB12 plasmid. The resulting plasmid pCB12sp was transferred through con-
jugation into the CA and CAR strains. The inactivation of the hasA gene in the resulting recom-
binant strains was confirmed by PCR with appropriate primers and phenotypic characterisation
(Alcian blue and India ink staining).
RNA isolation and expression analysis
Bacterial precultures were grown overnight in BHI broth (37°C, 200 rpm). Experimental cul-
tures were diluted 1:25 in fresh medium and subcultivated either in BHI broth in ambient air
or in BHI broth containing 0.8% (w/v) sodium bicarbonate in 5% CO2 atmosphere. AtxA
expression was induced in the pDAC-atxA complemented strain (Table 1) by adding IPTG
(1 mM final concentration) one hour after subcultivation.
The bacterial pellet corresponding to 1 ml of bacterial culture in late log phase was resus-
pended immediately in boiling lysis buffer (2% SDS, 16 mM EDTA, 20 mMNaCl) and incubat-
ed for 5 min at 95°C. After addition of 3 M sodium acetate on ice and cooling, nucleic acid
extraction was performed with a 25:24:1 mix of phenol:chloroform:isoamyl alcohol. Samples
were incubated for 15 min on ice and were centrifuged (12000 x g at 4°C for 5 min). The upper
phases were recovered and a 1/10 volume of each 3 M sodium acetate and 1 mM EDTA and
2.5 volumes of ice-cold ethanol were added. Samples were incubated at -80°C for at least one
hour to precipitate RNA. After centrifugation (12000 x g at 4°C for 30 min), pellets were resus-
pended in RNase-free water and RNA was further purified with an RNeasy Mini Kit (Qiagen,
Hilden, Germany) according to the manufacturer´s instructions. After elution with RNase-free
water, total RNA concentrations were measured by UV spectrophotometry (Nanodrop,
Thermo Scientific, Wilmington, USA) and RNA quality was assessed by measuring the ratio of
absorbance at 260 and 280 nm.
For reverse transcriptase (RT)-PCR, purified RNA (3 μg) was treated with DNase according
to manufacturer's protocol (Fermentas, St. Leon-Roth, Germany) and the absence of contami-
nating DNA was verified by PCR. Reverse transcription was carried out with 1 μg of DNA-free
total RNA for 1 h at 42°C. The M-MLV RT-System (Invitrogen) was used and the reaction ad-
ditionally contained 2 μl (10 μM) gene specific cDNA-primer (Table 2, cDNA), 2 μl (10 mM)
dNTPs and 1 μl RNase inhibitor (Fermentas, St. Leon-Roth, Germany).
PCR amplification of the hasA, capB and gyrB gene fragments was performed in a 25 μl final
volume with 2.5 μl 10X buffer, 0.2 mM of each dNTP, 1.5 mMMgCl2, 0.2 μM concentrations
Table 2. Oligonucleotides for expression analysis used in this study.
Oligonucleotides Sequence
hasA- cDNA GTACGATTAAGTCAGGAATACC
hasA-for TAAACCTTATACGTCCTATGAG
hasA-rev TGAGTTCTAAGAAGTTCCTCC
capB-cDNA GATAATCGGGTTGAACTGCC
capB-for GGGAAAACAACTGGTACATCTGC
capB-rev AAGTGCTTCTGCTTCTAAATCAGC
gyrB-cDNA TCATGTGTTCCACCTTCATAC
gyrB-for CAGGGTACTGTGACGAAATTAACG
gyrB-rev CACCATGCAAACCACCAGAAAC
doi:10.1371/journal.pntd.0003455.t002
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of each primer (Table 2, for and rev), 0.6 units of Taq polymerase (Fermentas, St. Leon-Roth,
Germany), and 1 μl of cDNA. The PCR program consisted of one step at 94°C for 5 min, fol-
lowed by 35 cycles consisting of 94°C for 30 s, 55°C for 30 s and 72°C for 30 s, and a final step
at 72°C for 10 min. The PCR products were separated on a 1.5% agarose gel and were stained
with ethidium bromide. The size of the PCR product of hasA, capB and gyrB were 456 bp, 144
bp and 195 bp, respectively. All primers were supplied by Metabion (Martinsried, Germany).
Sequence analysis
For sequencing of the has operon and the atxA gene, PCR fragments were generated from ge-
nomic DNA of the CAR, CAR-P and derivative strains (S1 Table), were processed by standard
procedures [37] and were then sequenced with an AB3100 DNA sequencer (Applied Biosys-
tems, Foster City, USA). Sequences were compiled and analysed with the Gap4 software (The
Staden package, 1998—PMID: 10547834).
Characterisation of capsules and toxins
Capsule-inducing agar plates were used as described previously [28,38]. The presence of a cap-
sule was visualised under a microscope after India ink staining. Where required, bacterial cul-
tures were incubated with 200 units of hyaluronidase (H3506, Sigma-Aldrich, Lyon, France),
for 30 min in sodium phosphate buffer before India ink staining. The PDGA capsule was de-
tected by immunofluorescence labelling of bacteria with a PDGA-specific polyclonal antiserum
as previously described [10].
Bacterial cultures were grown overnight at 37°C on BHI agar containing 0.8% (w/v) sodium
bicarbonate in a 5% CO2 atmosphere. IPTG (1 mM final concentration) was added to the agar
to induce atxA gene expression in the CAR20-pDAC-atxA strain. One loop of colony material
was resuspended in 0.5 ml phosphate-buffered saline (PBS, pH 7.2). Where required, 50 μl of a
hyaluronidase (Sigma-Aldrich, Taufkirchen, Germany) stock solution (10 mg/ml in PBS, cor-
responding to 4,000–10,000 Units per ml according to the manufacturer) was added to the
bacterial suspension and incubated for 30 min at 37°C. The reaction was stopped by heating at
95°C for 10 min. The colony suspension was centrifuged for 20 min at 12000 x g and the super-
natant containing capsule material was filter-sterilised (0.2 μm pore size). The samples were
analysed by 5% sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (PAGE) by
standard procedures (running buffer: 25 mM Tris, 192 mM glycine, 0.1% SDS, pH 8.3). Prior
to loading, 7.5 μl of the supernatant was mixed with 2.5 μl of 4 x Laemmli loading buffer and
was heated at 95°C for 5 min. After electrophoresis at 20 mA for approximately 2 hours, the gel
was fixed in 10% acetic acid, 40% ethanol for at least 1 hour. The fixing solution was replaced
by Alcian blue (Sigma-Aldrich) solution (0.025% Alcian blue in fixing solution) and gently
agitated for 30 min. The gel was then destained in fixing solution [39,40]. The stained gels
were visualised with the ChemiDoc MP System with Image Lab Software (BioRad, Munich,
Germany).
Toxin components PA and LF were detected by western blot of bacterial culture superna-
tants derived from cultures grown overnight in R medium supplemented with 0.8% bicarbon-
ate in 5% CO2 at 37°C. The monoclonal antibodies against PA and LF and the western blotting
procedure were described previously [33].
Determination of virulence and immunoprotection
Outbred OF1 female mice (6 to 8 weeks old) and Hartley guinea pigs (200 to 250 g) were pur-
chased from Charles River (L'Arbresle, France). The animals were housed in the BSL3 animal
facilities of the Institut Pasteur licensed by the French Ministry of Agriculture and complying
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with European Union regulations. The protocols were approved by the Institut Pasteur Safety
Committee, according to the standard procedures recommended by the Institut Pasteur Ani-
mal Care and Use Committee. Mice and guinea pigs were infected subcutaneously in the flank
with graded doses of spores in 200 μl PBS. Intranasal inoculation was performed in lightly
anesthetised animals by depositing onto the nostril graded doses of spores in 20 μl of PBS. CFU
number in the inoculum was retrospectively checked by plating 10-fold dilutions on BHI agar.
Survival was monitored twice daily for at least 15 days. All calculations of virulence were per-
formed at least twice. Mean lethal doses (LD50) were calculated by the method of Reed and
Muench [41].
Immunoprotection experiments on mice were performed as previously described [42,43].
Briefly, 200 μl of a mix of 10 μg of recombinant PA (a kind gift from Dr Bassam Hallis, Public
Health England, Porton Down, UK) and 1 x 108 formaldehyde inactivated B. anthracis spores
of the RPLC2 strain (FIS), with 0.3% aluminium hydroxide gel (Sigma-Aldrich, St. Louis, MO)
in PBS were injected subcutaneously into the flank at day 0 and 14. Challenge with spores of
the B. cereus bv anthracis or B. anthracis strain was performed subcutaneously at day 35 and
survival was monitored for 20 days.
Bioluminescence imaging
Cutaneous infection was performed by injecting 10 μl of spore suspension in PBS into the der-
mis of the right ear pinna as described previously, or by depositing 20 μl of spore suspension
onto the nostril [30]. Images were acquired with an IVIS 100 system (Xenogen) according to
instructions from the manufacturer. Analysis and acquisition were performed with Living
Image 2.5 software (Xenogen). Unless otherwise noted, mice were anaesthetised with a con-
stant flow of 2.5% isofluorane mixed with oxygen. The XGI-8 Gas Anaesthesia System (Xeno-
gen) was used, which enabled control of the duration of anaesthesia. Images were acquired
with a binning of 16. Luminescent signals from the exterior of mice were acquired for 1 min.
All other photographic parameters were kept constant.
Electron microscopy
Encapsulated bacterial cells were fixed with 2.5% glutaraldehyde in 0.1 M cacodylate—5 mM
CaCl2 buffer (pH 7.2) as described previously and were postfixed for 2 h with 2% OsO4 in the
same fixation buffer [44]. The pelleted bacteria were embedded in 2% low-melting-point agar
(type IX; Sigma). The samples were then treated with 0.5% uranyl acetate in water for 1 h.
After extensive washing, small blocks were dehydrated with alcohol and embedded in Epon.
Thin sections were conventionally poststained and observed with a Jeol 1010 electron
microscope.
Statistical analysis
Data were processed with GraphPad PRISM 4 software to generate graphs and to carry out sta-
tistical analyses. Statistical evaluation of survival was performed with the log-rank test. Results
were expressed as mean values ± SD. Statistical significance was determined by Student’s t test.
Results
Contribution of PDGA capsule and toxins to the virulence of B. cereus bv
anthracis
B. cereus bv anthracis CA and CI strains harbour two virulence plasmids, pBCXO1 and
pBCXO2, that are highly similar to the virulence plasmids pXO1 and pXO2 characteristic of B.
Virulence Factors of Emerging Bacillus cereus Biovar anthracis
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anthracis. We thus examined the virulence of these two strains in two complementary animal
models, mice and guinea pigs, and by the two main routes of infection, subcutaneous and
intranasal.
When the CA and CI strains were delivered by the subcutaneous route, the LD50 of the two
strains was similar both in mice (60 spores for CA and 130 spores for CI; Table 3) and in guinea
pigs (100 spores for CA and 300 spores for CI; Table 4). These values are similar to those re-
ported for the fully virulent B. anthracis 9602 strain (<25–40 spores in mice and 65 spores in
guinea pigs [45]). When the CA and CI strains were delivered by the intranasal route in mice,
both strains showed similar virulence with an LD50 close to the value for the B. anthracis 9602
strain (Table 3). We examined only the CA strain by the intranasal route in the guinea pig. The
LD50 was similar to that of the 9602 strain (1.2 x 10
7 spores for CA vs 2 x 107 spores for strain
9602) with a mean time to death of 5.9 ± 2.1 days (n = 6) for CA vs 4.0 ± 0.3 days (n = 6) for
strain 9602.
We then investigated the respective contribution of each main virulence factor, the polyglu-
tamate (PDGA) capsule and the toxins, to the virulence of the B. cereus bv anthracis CA strain.
The virulence of a CAP(ΔpagA) mutant lacking protective antigen and therefore toxin activity
(CAP strain, Table 3) was not modified in mice (LD50 by subcutaneous route 70 spores vs 60
spores for the parental CA strain) and its virulence was a 100-fold attenuated in the guinea pig
(104 for the mutant vs 102 for the CA strain; Table 4). To analyse the contribution of the poly-
glutamate capsule, the CA strain was cured of the pBCXO2 plasmid, resulting in the CAR
Table 3. Virulence of the Bacillus cereus bv anthracis and the CA derivative strains in mice.
Route Strain pBCXO1 pBCXO2 Virulence factors LD50 MTD (days)
Cutaneous CI + + Tox, HA, PDGA 130 3.2 ± 0.4
CA + + Tox, HA, PDGA 60 4.4 ±1.8
CA-P ΔpagA + HA, PDGA 70 4.7 ± 1.2
CAR + - Tox, HA 550 3.4 ± 0.4
CA-H ΔhasA + Tox, PDGA 70 3.4 ± 0.5
CAR-P ΔpagA - HA 6 x 107 2.1 ± 0.7
CAR-H ΔhasA - Tox 3 x 106 5.0 ± 1.3
Ba7702 pXO1 - Tox 4 x 105 3.75 ± 0.9
CAR-R - - - > 6 x 107* NA
CAR20 + - - > 1 x 108* NA
Intranasal CI + + Tox, HA, PDGA 3.5 x 104 3.1 ± 1.6
CA + + Tox, HA, PDGA 3.5 x 104 4.2 ± 0.7
CAR + - Tox, HA 2.5 x 104 4.5 ± 0.7
CA-H ΔhasA + Tox, PDGA 2.2 x 104 3.6 ± 1.8
CAR-P ΔpagA - HA 1 x 107 4.1 ± 1.5
CAR-H ΔhasA - Tox > 1 x 108* NA
Ba7702 pXO1 - Tox > 1 x 108* NA
Ba9602 pXO1 pXO2 Tox, PDGA 1 x 104 2.8 ± 0.7
Mice were inoculated with graded spore inocula of each strain in the flank or by the intranasal route (six animals per dose). The following information is
specified where applicable: (i) the presence of pBCXO1, PBCXO2 for the CI and CA-derived strains, and pXO1, pXO2 for the B. anthracis (Ba) Sterne
7702 and wild-type 9602 strains; (ii) the gene inactivated on pBCXO1; and iv) the virulence factors expressed—lethal and edema toxins (Tox), hyaluronic
acid capsule (HA) and polyglutamic acid capsule (PDGA)—is indicated for each mutant. Results are expressed as mean lethal dose (LD50) and mean
time to death in days (MTD, mean ± SD). Each experiment was performed at least twice. The asterisk denotes absence of mortality at the highest
inoculum tested. NA, not applicable.
doi:10.1371/journal.pntd.0003455.t003
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strain. The absence of the PDGA capsule was confirmed by the absence of immunofluores-
cence following the labelling of bacteria with a PDGA-specific polyclonal antiserum (Fig. 1A,
[10]). Toxin production in inducing conditions was not modified, as shown by immunoblot-
ting for PA and LF (Fig. 1B). Most strikingly, loss of the pBCXO2 plasmid did not modify viru-
lence when bacteria were delivered intranasally in mice, and the CAR strain remained as
virulent as the parental CA strain (Table 3). Furthermore, the virulence of CAR was only slight-
ly attenuated in mice and guinea pigs inoculated by the subcutaneous route (LD50 of CAR was
8-fold higher than that of CA in mice and was 10-fold higher in guinea pigs; Tables 3 and 4).
These results were unexpected, because curing B. anthracis of pXO2 (as in the 7702 Sterne
strain) results in the absence of virulence when the Sterne strain is delivered by the intranasal
route and a significant attenuation of virulence by the subcutaneous route (Table 3 with a LD50
for the 7702 Sterne strain of 4 x 105; [46,47]. These observations led to the development of the
veterinary Sterne vaccine strain after 1939 [48]. These properties of the CAR strain therefore
suggest the presence of additional virulence factor(s) in the parental CA strain.
Identification of a pBCXO1-encoded hyaluronic acid capsule as an
additional virulence factor for CA
CAR colonies grown on capsule-inducing agar medium still showed a somewhat smooth ap-
pearance, although this was less apparent than with the parental CA strain. We confirmed the
presence of capsular material surrounding the CAR bacteria by India ink staining (Fig. 1A).
We isolated a spontaneous rough colony of the CAR strain (CAR-R strain) on capsule-induc-
ing agar plates; the lack of any capsule was confirmed by India ink staining of CAR-R bacteria.
Multiplex PCR analysis of this rough clone showed that pBCXO1 was lost, suggesting that the
expression of the capsule in the CAR strain was linked to the presence of pBCXO1 (S1A Fig.).
We then investigated whether this capsule may be the pBCXO1-encoded hyaluronic acid
capsule (has operon), as recently reported for the pathogenic B. cereus G9241 strain [18]. DNA
sequencing of the hasACB operon of the CAR strain showed that, in contrast to B. anthracis
[8], the hasA gene is non-mutated and the deduced sequence of the HasA protein is identical
to the sequences available in the databases for the CI and G9241 strains. The HasC and HasB
protein sequences were also identical to those of the CI and G9241 strains, with only one mis-
match for HasB at position 209 (Ala!Thr) compared with the sequence from G9241.
We examined the role of the hasACB operon in the capsule produced by the CAR strain by
inactivating the hasA gene encoding the hyaluronate synthase. The resulting CAR-H(ΔhasA)
strain gave rough colonies on capsule-inducing agar and showed no capsule by India ink stain-
ing, suggesting that it was unable to synthesise a capsule (Fig. 1A). Hyaluronidase enzymatic
digestion of encapsulated bacteria confirmed the hyaluronic acid nature of this has operon-
Table 4. Virulence of the Bacillus cereus bv anthracis and CA derivative strains by the subcutaneous route in guinea pigs.
Strain pBCXO1 pBCXO2 LD50 MTD (days)
CI + + 300 5
CA + + 100 3.1 ± 0.3
CAP ΔpagA + 1 x 104 4.75 ± 1
CAR + - 2 x 103 5.2 ± 1.2
Guinea pigs were inoculated with graded spore inocula of each strain by subcutaneous route in the flank (four animals per dose). The presence of
pBCXO1 and PBCXO2 and the gene inactivated on pBCXO1 is specified where applicable. Results are expressed as mean lethal dose (LD50) and mean
time to death in days (MTD, mean ± SD). Each experiment was performed at least twice.
doi:10.1371/journal.pntd.0003455.t004
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encoded capsule in the CAR strain; this treatment led to a complete absence of the capsule as
visualised in Fig. 1A. The CA strain, and the CI (through database sequence analysis [24]), thus
harbour genetic determinants encoding a PDGA capsule on pBCXO2 and a HA capsule on
pBCXO1.
We visualised the capsules produced by the CA and CI strains through Alcian blue staining.
SDS-PAGE with low concentrations of acrylamide revealed two high molecular weight bands
in bacterial extracts of these strains (Fig. 2A). The lower band was present in all PDGA-ex-
pressing strains, i.e. the PDGA-encapsulated B. anthracis Vollum strain and the CA and CI
Fig 1. TheB. cereus bv anthracisCA strain expresses a PDGA and a HA capsule, and toxins. (A) Capsule expression in the CAP(ΔpagA), the CAR
and the CAR-H(ΔhasA) strains in inducing conditions; the polyglutamate (PDGA) and hyaluronic acid (HA) capsule was visualised by immunofluorescence
with a polyclonal anti-PDGA immune serum or by India ink staining; degradation of the HA capsule was achieved by incubation with hyaluronidase as
described in the Materials and Methods section. (B) The production of toxin components PA and LF in overnight bacterial culture supernatants was
determined by western blot with or without CO2/bicarbonate as described in the Materials and Methods section.
doi:10.1371/journal.pntd.0003455.g001
Virulence Factors of Emerging Bacillus cereus Biovar anthracis
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003455 April 1, 2015 10 / 27
strains; it was absent in the strains that do not produce a PDGA capsule, i.e. the pBCXO1+
pBCXO2-cured CAR strain and the plasmid-free CAR-R strain. The upper band was present
in the CA and CI strains, and in the CAR strain that expresses a HA capsule; it was absent
from the CAR-H(ΔhasA) and CAR-R strains, and from the B. anthracis Vollum strain, that do
not produce the HA capsule. Furthermore, hyaluronidase enzymatic digestion of the bacterial
extracts led to the disappearance of the upper band for the CI, CA and CAR strains (Fig. 2A).
These data suggest that the two high molecular weight bands detected in the CA and CI
samples represent the PDGA (lower band) and the HA (upper band) capsular material. Fur-
thermore, this shows that, in inducing conditions, both capsules are concomitantly expressed
at the CA and CI bacterial surface. To address the relative contribution of each capsule to viru-
lence in the presence of toxins, the hasA gene was inactivated in the CA strain, leading to a
PDGA-encapsulated mutant; its virulence was not modified both by subcutaneous and intrana-
sal routes in mice (Table 3, CA-HΔhasA strain). As shown above (Table 3), the virulence of the
HA-encapsulated CAR strain was unaffected by intranasal route, though a slight reduction was
observed by subcutaneous route. Thus each capsule contributes to virulence in the presence of
toxins and may favour entry through inhalational route.
Ultrastructural analysis by TEM (Fig. 3) showed the HA-capsule consists of fine filaments
of homogenous density surrounding the entire bacterial CAR surface. This structure was ab-
sent in the CAR-H(ΔhasA) mutant (Fig. 3). In a CA-H(ΔhasA) mutant, which lacks the HA-
capsule but produces a PDGA-capsule, the organisation of the filaments surrounding the bac-
teria was distinct from that observed for CAR (Fig. 3). In the parental CA strain, which pro-
duces the two types of capsules, the resulting capsular structure appeared different from the
structures surrounding the HA-expressing CAR and PDGA-expressing CA-HΔhasA strains
(Fig. 3).
Co-regulation of the expression of the HA and PDGA capsules
We only observed the encapsulated phenotype of the CAR strain when CO2/Bicarbonate was
present in the culture conditions, either in solid or liquid media. This suggests that inducing
conditions similar to those described for the PDGA-capsule in B. anthracis are required for the
expression of the HA-capsule. Molecular analysis by RT-PCR showed that the hasA transcript
in the CA, CI and CAR strain was present only when cells were cultured under CO2/Bicarbon-
ate inducing conditions, and was absent, as expected, in the CAR-H(ΔhasA) strain (Fig. 2B). In
the CA and CI strains, both hasA and capB transcripts were detected under the same inducing
conditions (Fig. 2B), indicating that their expression is coregulated.
We investigated further the mechanism of HA capsule regulation by examining the proper-
ties of a spontaneous rough mutant strain, CAR20, that was isolated in culture under 20% CO2.
Multiplex PCR showed that this mutant strain still harbours pBCXO1. We examined the prop-
erties of this strain in inducing conditions: India ink staining revealed the absence of a capsule
(Fig. 4A) and no band was detected through Alcian blue staining (Fig. 4B). DNA sequencing
showed no mutation in the hasACB operon (S2A Fig.) that could account for this defect in HA
capsule synthesis. However, analysis of toxin production showed that the non-encapsulated
CAR20 strain was also unable to produce the toxin components PA and LF (Fig. 4C). These
properties therefore strongly suggest that this strain carries a central defect that affects the reg-
ulation of PA, LF and the HA capsule. In B. anthracis, AtxA is the central regulator encoded by
pXO1 that controls the expression of virulence factors under inducing environmental condi-
tions. The atxA gene is also present on pBCXO1 ([20,24]); therefore, we hypothesized that
AtxA is involved in has operon expression and may be defective in the CAR20 strain.
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Fig 2. Coexpression of a PDGA and a HA capsule by the B. cereus bv anthracis strains. (A) Alcian Blue staining was performed on filtrates of colony
lysates from various strains grown in CO2/bicarbonate conditions: these were the Vollum strain (wild-type B. anthracis), the B. cereus bv anthracisCI and CA
strains, and the CA-derived strains devoid of pBCXO2 (CAR) and further deleted in the hasA gene (CAR-H) or having lost pBCXO1 (CAR-R); hyaluronidase
treatment was performed before PAGE, as described in the Materials and Methods section. (B)mRNA of the hasA gene (involved in synthesis of the HA
capsule) and the capB gene (involved in synthesis of the PDGA capsule) was assessed in the strains described in (A) grown under CO2/bicarbonate (CO2) or
aerobic (O2) culture conditions as described in the Materials and Methods section; gyrB gene expression was used as reference.
doi:10.1371/journal.pntd.0003455.g002
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Comparison of atxA gene sequence of the CAR20 strain with that of the parental CAR strains
showed three Single Nucleotide Polymorphisms at positions 153 (A to T), 157 (G to C) and 159
(C to A), and one base insertion at position 161 (T). These alterations result in amino acid
changes at positions 51 (Leu to Phe) and 53 (Asp to Gln) and a shift of the reading frame after
the 54th amino acid that introduces a stop codon (TGA) at position 77 (Table 5 and S3 Fig.). We
confirmed the involvement of AtxA in HA-capsule production by complementation experi-
ments. Introduction of a wild-type copy of the B. anthracis atxA gene into the CAR20 strain led
to detection of hasAmRNA (S1B Fig.) and restored the production of the HA capsule (Fig. 4A &
B) and of both PA and LF (Fig. 4C). Furthermore, the capsule in the complemented strain was
completely digested by hyaluronidase, confirming that it was composed of HA (Fig. 4A & B).
Our data thus show that HA-capsule expression in the B. cereus bv anthracis CA strain is regulat-
ed by AtxA.
We consistently observed that rough mutants formed at the edges of smooth colonies after
48h of growth on capsule-inducing solid medium under 5% CO2. We screened fifteen sponta-
neous rough mutants of the CAR and CAR-P strains for LF production; none produced LF.
Multiplex PCR analysis showed that two mutants had lost pBCXO1. We determined the se-
quence of the atxA gene in the remaining thirteen non-encapsulated mutants. All thirteen
Fig 3. Ultrastructural analysis of the capsules of the B. cereus bv anthracisCA strain and its derivatives. Bacterial cells from the PDGA and HA
capsule-expressing CA strain and its derivatives expressing a HA capsule (CAR), a PDGA capsule (CA-H(ΔhasA)) or no capsule (CAR-H(ΔhasA)) were
prepared for Transmission Electron Microscopy as described in the Materials and Methods section. Scale bar: 500nm
doi:10.1371/journal.pntd.0003455.g003
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strains carried mutations in the atxA gene (Table 5 and S3 Fig.). Two mutants carried one base
change leading to an amino acid substitution: either Ser to Pro (CAR2) or Pro to Thr (CAR4).
These two mutations were located in the winged helix-turn-helix WH region in the N-terminal
part of AtxA [49,50]. Three other mutations, located in the Phosphotransferase Regulation
Fig 4. Expression of the HA capsule is regulated by AtxA. Complementation of the CAR20 strain with the pDACatxA plasmid restores capsule and toxin
expression after IPTG induction as observed by (A) India ink staining, (B) Alcian Blue staining of the bacterial culture supernatants, and (C) PA and LF toxin
component production as described in Figs. 1 and 2 and in the Materials and Methods section. Hyaluronidase treatment confirms the HA nature of the
capsule (A,B).
doi:10.1371/journal.pntd.0003455.g004
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domain PRD2, resulted in either the addition of one (CAR-P8) or loss of one (CAR1, CAR5) of
the two VNTRs (encoding the sequence Tyr-Asn) present in this region. The eight other atxA
mutants had either a deletion or an insertion of a single base introducing a frameshift muta-
tion. Six were located in the Mga-like helix-turn-helix HTH region; five of them affected codon
141, another insertion (CAR-P3) was located between the PRD1 and PRD2 domains, and an-
other one (CAR-P1) was in PRD2 (Table 5).
Respective roles of the HA capsule and toxins in virulence and
dissemination
We found that despite the absence of pBCXO2—and thus of the PDGA capsule—in the CAR
strain, this strain nonetheless exhibited high virulence both in mice and guinea pigs (Tables 3
and 4). Therefore, we investigated the specific contributions of the HA capsule and the toxins
to the high virulence of the CAR strain. We constructed CAR-derived mutants lacking each of
these virulence factors and examined their virulence when delivered by subcutaneous or intra-
nasal routes in mice.
We inactivated the pagA gene in the CAR strain resulting in the non-toxinogenic CAR-P
(ΔpagA) strain. This HA-encapsulated strain still retained virulence when delivered by the in-
tranasal route in mice, and its virulence was only a 400-fold lower than that of the CAR strain
(LD50: 10
7 spores vs 2.5 x 104, Table 3). In contrast, its virulence was highly attenuated in mice
inoculated by the subcutaneous route, and was approximately 100,000-fold lower than that of
the CAR strain (LD50: 6 x 10
7 spores vs 550, Table 3).
Elimination of the HA capsule in the CAR strain (CAR-H(ΔhasA) strain, see above) led to a
non-encapsulated strain (Figs. 1A & 2) that still produced PA and LF (Fig. 1B). This strain can
thus be considered as equivalent to the B. anthracis Sterne strain. The CAR-H(ΔhasA) strain
was avirulent when delivered by the intranasal route, as is the 7702 Sterne strain, (Table 3).
However, this strain exhibited residual virulence when delivered by the subcutaneous route,
with a virulence 5,500-fold lower than that of the CAR strain, but only 10-fold lower than that
of the Sterne strain (Table 3).
Table 5. Characterisation of the spontaneous mutations in AtxA.
AtxA
domains*
WH HTH PRD1—PRD2
Codon position 6 51 53 54 74 104 141 286 322 332
Mutation
type**
SNP SNP SNP SNP INS SNP INS DEL INS INS INS VNTR
Base Change T > C A > T G >
C
C >
A
T C > A A A A A A ATTATA
AA Change§ Ser >
Pro
Leu >
Phe
Asp > Gln — Pro >
Thr
— — — — — Tyr, Asn
Premature stop
codon
— + — + + + + + —
Mutant CAR2 CAR20 CAR4 CAR-
P2
CAR3CAR-
P5CAR-P6
CAR-
P7CAR-P12
CAR-
P3
CAR-
P1
CAR1CAR5CAR-
P8
*The AtxA domains were defined according to (Hammerstrom et al., 2011) WH, Winged Helix-turn-helix; HTH, Mga-like Helix-Turn-helix; PRD,
PhosphoTransferase Regulation Domain.
**SNP, Single Nucleotide Polymorphism; INS, Insertion; DEL, deletion; VNTR, Variable Number Tandem Repeat
§AA, amino Acid
doi:10.1371/journal.pntd.0003455.t005
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Elimination of both virulence factors (toxins and HA capsule) either after loss of pBCXO1
(CAR-R strain) or through mutations inactivating the central regulator atxA (CAR20 strain),
resulted in the absence of virulence in mice inoculated by the subcutaneous route (Table 3).
This shows that no additional factor on the B. cereus chromosomal background significantly
contributes to virulence of the CA strain in the absence of the toxins and the PDGA and
HA capsules.
We investigated further the role of each virulence factor in bacterial colonisation and dis-
semination. Bioluminescent derivatives were constructed in strains expressing the HA-capsule
only (CAR-P(ΔpagA)), the HA-capsule together with the toxins (CAR), and the HA capsule to-
gether with the PDGA-capsule(CAP(ΔpagA)). Mice were infected with these strains by cutane-
ous route in the ear pinna or by intranasal route. All mice that were cutaneously infected with a
strain expressing only the polysaccharidic HA-capsule (CAR-Plux strain) exhibited a biolumi-
nescent signal in the infected site (Fig. 5A) that was contained locally throughout the infection.
The bioluminescent signal initially increased, but subsequently decreased and disappeared by
day 8, after which no bioluminescence signal was detectable in the draining lymph node, spleen
and lungs.
Intranasal infection with 108 spores of the CAR-Plux strain resulted in detection of a biolu-
minescent signal in five out of 13 animals (38%) in the dorsal region of the head. The biolumi-
nescent bacteria remained restricted to this area throughout the infection (Fig. 6Aa) and no
bioluminescence signal was detectable in the draining lymph node, spleen and lungs. All mice
presenting a bioluminescence signal died in the 24h following the detection of the signal. Nec-
ropsy showed a bioluminescent focus of infection associated with the brain (Fig. 6Aa bottom)
and the floor of the cranial chamber was bioluminescent. Histological analysis showed that the
infection had disseminated to the central nervous system (Fig. 6Ab-e). A diffuse inflammatory
lesion was centred on the leptomeninges and peripheral Virchow-Robin spaces (Fig. 6Ab).
This lesion was characterised by haemorrhages, oedema, a marked infiltration of neutrophils
(Fig. 6Ad), and a very high density of bacteria (Fig. 6Ac). The presence of multifocal extensions
of inflammatory infiltrates in peripheral cerebral parenchyma, associated with a destruction of
the neuropil and intra-parenchymal infiltration of bacteria (Fig. 6Ae) is highly suggestive of a
multifocal rupture or permeability modification of the blood-brain barrier.
When the toxins were co-expressed with the HA-capsule (CARlux strain), bioluminescent
bacteria disseminated from the initial site of cutaneous infection, i.e. the ear pinna (Fig. 5B), to
the draining lymph node, and then to the spleen and lungs just before death. Intranasal infec-
tion with the CARlux strain resulted in the detection of a bioluminescence signal in the naso-
pharynx of 81% of the animals (9 out of 11); bioluminescent bacteria then spread to the
draining cervical lymph node and the spleen (Fig. 6B). For two of the infected mice, no signal
was detectable in the nasopharynx, although subsequent systemic dissemination was similar
(S1C Fig.).
When both PDGA and HA capsules were co-expressed in the absence of toxins (CAPlux
strain), bioluminescent bacteria initially multiplied at the site of cutaneous infection (the ear
pinna), following which they spread to the draining lymph node, spleen and lungs (Fig. 5C).
When bacteria were administered intranasally, no signal was detectable at the site of entry (na-
sopharynx), whereas local and systemic dissemination was essentially similar to what we ob-
served during cutaneous infection, i.e. draining lymph node, spleen and lungs (Fig. 6C).
In conclusion, the bacterial pattern of colonisation and dissemination was profoundly mod-
ified when bacteria expressed either the toxins or the PDGA-capsule together with the HA-
capsule.
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Fig 5. In vivo dissemination of the B. cereus bv anthracisCA strain during cutaneous infection in mice.Mice were inoculated into the ear pinna with
spores of (A) CARP-lux (9 mice, inoculum 1 x 107; all mice survived), (B) CAR-lux (8 mice, inoculum 1 x 105; all mice died), or (C) CAP-lux (11 mice, inoculum
1 x 105; all mice died) strains and bioluminescence was analysed at the indicated times after infection (D: days). These image series show a representative
dorsal and ventral view of the same mouse for the various strains. Black and white photographs are overlaid with false-colour representation of luminescence
intensity expressed in photons s -1 cm2 sr -1.
doi:10.1371/journal.pntd.0003455.g005
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Fig 6. Local role of the HA capsule and in vivo dissemination of the B. cereus bv anthracisCA strain during intranasal infection in mice.Mice were
inoculated intranasally with spores of (A) CARP-lux (13 mice, inoculum 1 x 108), (B) CAR-lux (16 mice, inoculum 1 x 106; all mice died), or (C) CAP-lux (14
mice, inoculum 1 x 106; all mice died) strains and bioluminescence was analysed at the indicated times after infection as in Fig. 5 (D: days). (Ab-e)
Histological characterisation of the infected brain tissue shown inAa, bottom panel; (Ab) Diffuse inflammatory lesion centred on leptomeninges (LM),
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Efficiency of the FIS+PA vaccine in immunoprotection against infection
with the B. cereus bv anthracis CA and CI strains
An important issue following the emergence of these strains is whether anthrax vaccines can
protect against infection by these bacteria. We tested the efficacy of the formaldehyde inacti-
vated spore (FIS) + PA (Protective antigen) vaccine ([42]) during sub-cutaneous infection of
mice with spores of the B. cereus bv anthracis strains. We first tested immunoprotection against
a challenge with spores of the fully virulent B. cereus bv anthracis CA and CI strains expressing
both PDGA and HA capsules together with the toxins. Protection was afforded only when both
FIS and PA were used in the immunisation regimen (Fig. 7), and no significant protection was
obtained when FIS or PA was used alone. This finding is consistent with that reported for a
fully virulent B. anthracis strain ([42], and Fig. 7). In contrast, when we challenged mice with
the CAR strain that expressed only the HA-capsule and the toxins, immunisation with FIS
alone led to partial protection and immunisation with PA alone led to total protection (Fig. 7).
Discussion
Our study shows that the virulence of the pBCXO1- and pBCXO2-harbouring CA and CI
strains is similar to that of wild-type B. anthracis in mice and guinea pigs inoculated either
through cutaneous or inhalational routes. However, loss of pBCXO2—and thus of the PDGA
capsule while retaining toxin production—did not affect the virulence by inhalational route
and only moderately impaired it by cutaneous route (8- to 10-fold increase in LD50). This is in
clear contrast with B. anthracis, where the loss of pXO2, as in the Sterne strain, leads to signifi-
cant attenuation. Indeed, intranasal delivery of the Sterne strain in immunocompetent mice is
associated with an absence of virulence, while cutaneous infection results in significant attenua-
tion (>1,000-fold) in mice and guinea pigs [7,46,47].
Here we show that the CA and CI strains also possess a hyaluronic acid (HA) capsule that
plays a significant role as an additional virulence factor. It is encoded by the has operon, located
on pBCXO1, that we show to be functional both in the CA and CI strains, in contrast to B.
anthracis that contains a non-functional hasA gene [8,19]. Our analysis of the available genome
data for the pathogenic encapsulated B. cereus 03BB102 strain also revealed a wild type hasA
gene, as reported for the B. cereus G9241 strain [18].
The B. cereus bv anthracis CA and CI strains are the first examples in which the PDGA cap-
sule coexists simultaneously with another type of capsular structure. We also demonstrate that
CO2/bicarbonate and the central regulator AtxA are necessary for synthesis of the HA capsule,
similar to their requirement for the expression of the PDGA capsule in B. anthracis. Expression
of the has operon is strongly upregulated in B. cereus G9241 under CO2/bicarbonate conditions
[51]. We implicate AtxA in this process by isolating spontaneous mutants in atxA in the B. ce-
reus bv anthracis CAR/CAR-P strains; these mutants were avirulent, devoid of capsule and did
not produce toxins. Complementation with a wild-type atxA gene led to restoration of capsule
and toxin production. Thus, the has operon, located on pBCXO1 outside the pathogenicity is-
land [8] may be assigned to the AtxA regulon in B. cereus bv anthracis. The atxAmutations
were mainly located in the domains that are reported to be potentially involved in DNA bind-
ing and phosphotransferase regulation. These domains have also been described in MgA,
which is a global regulator of virulence in group A Streptococcus [49,50]. AtxA gene expression
multifocally extending to the brain parenchyma (star); (Ac) high density of bacteria in the leptomeninges and Virchow-Robin spaces; (Ad) inflammatory
infiltrates consisting of neutrophils, haemorrhages and oedema provoking a marked distension of leptomeninges and (Ae), at higher magnification, extending
to the cerebral parenchyma with the presence of bacteria in the neuropil (arrowhead) highly suggestive of a rupture of the blood-brain barrier. (Ab & d): HE
staining; (Ac & e): Gram staining.
doi:10.1371/journal.pntd.0003455.g006
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is high in CO2/bicarbonate culture conditions [51]. Dimerisation of AtxA in these conditions
leads to high AtxA activity and upregulation of the AtxA regulon [49]. AtxAmutations oc-
curred at a high frequency in CAR/CAR-P strains grown under these conditions. Noteworthy,
occurence of such atxAmutations was not observed in B. anthracis, using bioluminescence as a
marker of AtxA-dependent gene expression with the PpagA-lux 9602R-derived bioluminescent
strain [52].
Fig 7. FIS+PA vaccine provides protection against subcutaneous challenge with the CA and CI strains in mice.Mice were immunised
subcutaneously with rPA (10μg) and formaldehyde inactivated spores (FIS; 1 x 108) at day 0 and 15, and were challenged with spores of the B. cereus bv
anthracisCA (460 spores), CI (1150 spores), CAR (400 spores) or the B. anthracis 9602 (480 spores) strain as described in Materials and Methods. Survival
was followed over a 20-day period. Results are representative of at least two independent experiments that gave similar results (six mice per group).
Statistical significance was calculated by the log-rank test with GraphPad Prism software (p< 0.001; comparisons were made between the group immunised
with PA+FIS versus that immunised with Al2O3 for each strain).
doi:10.1371/journal.pntd.0003455.g007
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Under CO2/bicarbonate conditions, the expression of numerous genes on the chromosome
and pXO1 is upregulated to a higher extent in the pathogenic B. cereus G9241 strain than in
the B. anthracis Sterne strain [51]. Therefore, it could be proposed that high expression of
AtxA-controlled genes under CO2/bicarbonate conditions in the B. cereus CA strain has a dele-
terious effect on bacterial growth that may lead to the selection of atxA-inactive mutants.
Genes belonging to the Atxa regulon, and more generally CO2/ bicarbonate regulated genes,
[51,53,54] clearly need to be further characterised in B. anthracis and the emerging pathogenic
B. cereus CA and CI strains, especially as these B. cereus strains harbour the pBCXO1 and
pBCXO2 plasmids in a different chromosomal background.
The HA capsule strongly contributed to virulence in the absence of the PDGA capsule. Bac-
teria of the toxinogenic pBCXO1+ CAR(ΔhasA) strain in which the hasA gene was inactive
were avirulent in animals inoculated by inhalational route and their virulence was also strongly
attenuated in animals inoculated cutaneously. The virulence of this CAR-H(ΔhasA) strain was
not however, equivalent to that of the B. anthracis pXO1+ Sterne strain, although both strains
express the toxins without any capsule. Virulence was 7.5-fold more attenuated for the CAR-H
strain than for the Sterne strain, which may be related to differences in genetic background,
regulatory networks or phenotypic properties that need to be addressed. Our study, and the
clinical context in which the pathogenic G9241, 03BB102, 03BB87 and Elc2 B. cereus strains
were isolated, therefore highlight the potential role of a polysaccharide capsule as a virulence
factor. This factor may provoke fatal anthrax-like pulmonary infections in humans, as reported
in US metal workers [13,14].
The CARP strain (HA+Tox-) does not produce toxins but retains HA-capsule expression.
The virulence of these bacteria was highly attenuated in mice inoculated either cutaneously or
intranasally. However, attenuation was less pronounced when bacteria were delivered by inha-
lational (500-fold) than by the cutaneous route (100,000-fold). Interestingly, the residual viru-
lence of the HA+Tox- strain delivered by inhalational route is associated with a different
mechanism of dissemination than that reported for a PDGA-encapsulated non-toxinogenic B.
anthracis strain [30]. We used a HA+Tox- bioluminescent derivative to examine bacterial dis-
semination in vivo. We show that bacterial multiplication remains local and that dissemination
occurs from the nasopharynx to the adjacent brain, leading to lepto-meningo-encephalitis and
death. The cribriform plate of the ethmoid bone has been suggested to be involved in the dis-
semination of pathogens present in the nasal cavities such as bacteria, virus and parasites
along the olfactory nerves to the olfactory bulb and the meninges and subarachnoid space
[55,56,57,58]. One may speculate whether this could be the case during infection with the
HA+Tox- CARP mutant bacteria.
These observations show that the HA capsule may lead to a more successful infection and
may provide a survival advantage for the bacterium when it enters the infected host by the re-
spiratory route. Group A Streptococcus, a major human pathogen, also produces a HA capsule
that is involved in the colonisation of the upper airways [59]; this capsule is a virulence factor
encoded by a similar has operon in response to host environmental signals [60].
Toxin expression was essential for enhanced virulence in the presence of the HA capsule
(CAR strain). Indeed, bacteria expressing both the HA-capsule and toxins showed a profound-
ly different pattern of infection to that of the HA+Tox- strain. Intranasal delivery of the CAR
strain was associated with local bacterial multiplication in the nasopharynx, followed by local
and systemic dissemination, and death. Similarly, during cutaneous infection, the biolumines-
cent HA+Tox- strain remained localised to the initial infected site, whereas co-expression of
the toxins with the HA capsule enabled efficient local and systemic bacterial dissemination
leading to death. Similarly, toxin expression in the presence of the PDGA capsule (and in ab-
sence of the HA capsule, CA-HΔhasA strain) led to systemic dissemination; no signs of
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neuropathological involvement were observed during infection with this strain. To note, this
strain could be considered as an equivalent of wild-type B. anthracis, expressing toxins and the
PDGA capsule: dissemination to the brain was never observed in the mouse model of infection
[30,45]. This effect of the toxins in promoting systemic dissemination is similar to what has
been reported for B. anthracis [45,61].
We confirmed the synergistic action of the toxins and the HA-capsule in virulence through
immunisation/vaccination experiments. Immunisation with PA alone was sufficient for the
host immune defences to control the infection by the HA+Tox+ CAR strain. Once the toxins
are neutralised, the HA capsule does not by itself lead to the successful spread of infection.
Thus, a polysaccharide capsule does not impair the protection afforded by a PA-based vaccine,
as also shown for the B. cereus G9241 strain that produces two types of polysaccharide capsules
[62].
Our study also shows that co-expression of the PDGA capsule with the HA capsule in the
CAP strain leads to higher virulence than that of a HA-only encapsulated CARP strain. The
LD50 of this strain in mice was close to that of the parental CA and CI strains and dissemina-
tion was similar to that of B. anthracis [30,52,63]. These data confirm the role of the PDGA
capsule in the extreme susceptibility of mice to B. anthracis infection [7,42,64]. Furthermore,
as expected [42], immunisation with PA alone did not result in immunoprotection in the
mouse model of infection with this PDGA-expressing HA-encapsulated B. cereus strain. Addi-
tion of inactivated spores (FIS) to a PA-based vaccine was necessary to achieve total protection,
similar to what is required to protect against B. anthracis infection in mice [42]. Presence of a
HA-capsule thus does not alter the efficacy of the PA+FIS vaccine against infection with the B.
cereus bv anthracis strains. Therefore, the PA+FIS vaccine should provide a similar degree of
protection against both B. cereus bv anthracis infection and B. anthracis infection, in case this
emerging pathogen should disseminate in either animals or humans.
The B. cereus bv anthracis CA and CI strains represent a unique example of strains that may
be considered as at the borderline between B. cereus and the monomorphic B. anthracis. In-
deed, these strains display some characteristics thus far found only in B. anthracis and others
that are restricted to B. cereus strains. Similar to B. anthracis, the CA and CI strains (i) express
toxins and a PDGA capsule both regulated by AtxA; (ii) harbour pBCXO1 and pBCXO2 plas-
mids that are very close to the B. anthracis pXO1 and pXO2 (iii) show a similar virulence to
that of B. anthracis both in mouse and guinea pig models of infection; and (iv) have a pattern
of dissemination that resembles that of B. anthracis [30]. Moreover, they also share a "PlcR-
null" phenotype with B. anthracis, as PlcR-controlled enzymatic activities are not detected in
the CA and CI strains [20]. This contrasts with the great majority of B. cereus strains which
possess a functional PlcR [2], and also with the pathogenic pBCXO1-harbouring strains
[13,14,16]. However, the plcRmutation in the CI and CA strains ([24] and S2B Fig. respective-
ly) is different from that considered as characteristic of the B. anthracis lineage. This mutation
is present in all strains of B. anthracis thus far analysed, and is currently considered as a hall-
mark of the B. anthracis lineage [6,65]. The B. cereus bv anthracis strains CA and CI also pres-
ent some properties that associate them with pathogenic B. cereus strains: they belong to the
same phylogenetic group as B. cereus [2,24] and both B. cereus bv anthracis and pathogenic
pBCXO1-harbouring B. cereus strains express a HA capsule, due to a functional hasACB oper-
on. Interestingly, in silico analysis on 163 sequenced B. anthracis genomes (Sylviane Derzelle,
Guillaume Girault; personal communication) shows that the hasAmutation is present in B.
anthracis strains of both the A and B main branches. Therefore, the hasA frameshift mutation
may represent another characteristic of the B. anthracis lineage, and thus may be the first to be
located on the plasmid pXO1.
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If we consider the origin of the pBCXO1/pXO1-like plasmids, it is noteworthy that the path-
ogenic G9241, 03BB102, 03BB87 and Elc2 B. cereus strains were isolated from patients living in
rural zones of the same geographical area (Texas and Louisiana) where anthrax is endemic
[13,14,16]. However, the absence of the hasAmutation characteristic of B. anthracismakes it
unlikely that they acquired the plasmid from B. anthracis. Some environmental B. cereus
strains isolated in the same area are very similar to 03BB102, but are devoid of pBCXO1 [2,13]
These strains may play the role of recipient host during horizontal transfer with a still un-
known bacteria harbouring a pBCXO1 ancestor. An equivalent of the pBCXO1 must exist in
Africa, because it is present in the B. cereus bv anthracis CA and CI strains.
Our data show that acquisition of a pXO1-like plasmid carrying a functional has operon to-
gether with the toxin genes and the AtxA regulator clearly gives a selective advantage to the re-
cipient B. cereus. This event enables successful infection of the mammalian hosts, which would
lead to an increase in the bacterial biomass and to subsequent environmental contamination.
Further amplification cycles would then favour pathogen emergence and spread.
B. anthracis is thought to have evolved as a monomorphic lineage within the B. cereus
group, with a strict co-evolution between the chromosome and the two plasmids pXO1 and
pXO2. The B. cereus bv anthracis CA and CI strains may be considered as a new lineage among
the B. cereus group, that appeared through an ongoing co-evolution process similar to the
emergence of B. anthracis during the holocene [2,65]. It is tempting to speculate that pBCXO1
is an ancestor of the B. anthracis pXO1, which further evolved with pXO2 and the chromosom-
al genetic background.
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